SteelPeak Wealth LLC bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 55,944 shares of the real estate investment trust’s stock, valued at approximately $980,000.
Other large investors have also modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock worth $186,405,000 after buying an additional 7,872,150 shares during the last quarter. Nuveen LLC bought a new position in Healthpeak Properties during the 1st quarter worth approximately $124,113,000. Invesco Ltd. lifted its holdings in Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock worth $467,311,000 after buying an additional 3,967,830 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Healthpeak Properties by 57.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock worth $136,785,000 after buying an additional 2,477,307 shares during the last quarter. Finally, Amundi lifted its holdings in Healthpeak Properties by 89.4% during the 1st quarter. Amundi now owns 5,047,699 shares of the real estate investment trust’s stock worth $98,228,000 after buying an additional 2,382,657 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.
Insiders Place Their Bets
In other Healthpeak Properties news, CEO Scott M. Brinker acquired 2,930 shares of the company’s stock in a transaction dated Thursday, July 31st. The shares were acquired at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the purchase, the chief executive officer owned 210,416 shares of the company’s stock, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders bought 8,783 shares of company stock worth $150,129 in the last 90 days. 0.23% of the stock is owned by company insiders.
Healthpeak Properties Stock Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.Healthpeak Properties’s revenue for the quarter was down .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The business also recently announced a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.5%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s dividend payout ratio (DPR) is 508.33%.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on DOC. Wall Street Zen downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, July 7th. Weiss Ratings reissued a “hold (c-)” rating on shares of Healthpeak Properties in a report on Wednesday. Wells Fargo & Company cut their price target on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 27th. Raymond James Financial raised Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a report on Monday, September 15th. Finally, Cantor Fitzgerald began coverage on Healthpeak Properties in a report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target on the stock. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.33.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- Using the MarketBeat Stock Split Calculator
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- What is the Dogs of the Dow Strategy? Overview and Examples
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.